Ecolab Inc.
257.47-10.81 (-4.03%)
Oct 29, 4:00:02 PM EDT · NYSE · ECL · USD
Key Stats
Market Cap
73.02BP/E (TTM)
37.05Basic EPS (TTM)
6.95Dividend Yield
0%Recent Filings
8-K
Ecolab's Q3 EPS surges 13%
Ecolab reported third-quarter sales of $4.2 billion, up 4%, with organic growth of 3% from accelerating 3% pricing and 1% volume gains, led by strong Institutional & Specialty and Life Sciences segments while Basic Industries and Paper dragged. Adjusted diluted EPS hit $2.07, up 13%, as organic operating margin expanded 110 basis points to 18.7% despite growth investments. The company sharpened its 2025 adjusted EPS outlook to $7.48-$7.58, signaling 12-14% growth amid unpredictable geopolitics. Soft demand persists in underperforming units.
8-K
Ecolab issues $500M notes
Ecolab Inc. completed a $500 million offering of 5.000% notes due September 1, 2035, on August 27, 2025, following an underwriting agreement signed August 18. The notes, issued under an existing indenture, carry semi-annual interest starting March 1, 2026, and are redeemable early at specified prices. Proceeds will fund general corporate needs, including the previously announced Ovivo Electronics acquisition and debt repayment. Covenants restrict liens and certain transactions. Change of control triggers a 101% repurchase offer.
10-Q
Q2 FY2025 results
Ecolab's Q2 FY2025 results showed solid momentum, with net sales up 1% y/y to $4.0B despite the surgical solutions divestiture, driven by 3% organic growth from volume and pricing gains across segments. Operating income rose 8% y/y to $710M (derived), lifting margins to 17.6% amid productivity boosts and lower input costs, while diluted EPS climbed 8% y/y to $1.84, reconciling cleanly with 285.4M shares. Cash swelled to $1.9B on $1.1B YTD operating cash flow, funding $500M debt issuance and $380M dividends; free cash flow hit $616M (derived) after $455M capex. The One Ecolab initiative notched $49M cumulative savings. Yet competition in commoditized markets lingers as a balanced risk.
8-K
Ecolab appoints finance expert
Ecolab's board appointed Julie P. Whalen as an independent director on August 6, 2025, assigning her to the Audit and Finance Committees. With her CFO stints at Expedia Group and Williams-Sonoma, plus chairing Expedia's audit committee, Whalen brings sharp financial acumen to navigate global markets. Her expertise bolsters Ecolab's strategic planning and governance. No related transactions disclosed.
8-K
Ecolab Q2 EPS up 13%
Ecolab reported Q2 sales of $4.0 billion, up 1% but with organic growth of 3% driven by strong Institutional & Specialty and Water segments, while the surgical solutions sale dragged results. Adjusted diluted EPS hit $1.89, up 13%, fueled by value pricing and productivity gains that expanded organic operating margins to 18.3%. Growth engines like Life Sciences and Ecolab Digital surged double-digits. EPS growth persists. The company holds its 2025 adjusted EPS outlook at $7.42-$7.62 amid unpredictable markets, yet its supply chain resilience mitigates trade risks.
IPO
Website
Employees
Sector
Industry
CLH
Clean Harbors, Inc.
217.92-28.27
DD
DuPont de Nemours, Inc.
82.16+0.26
ECVT
Ecovyst Inc.
8.30-0.03
ESI
Element Solutions Inc.
26.43+0.21
HWKN
Hawkins, Inc.
158.58-6.65
IFF
International Flavors & Fragran
63.28-1.60
MTX
Minerals Technologies Inc.
55.09-1.50
PPG
PPG Industries, Inc.
99.13-6.18
TOMZ
TOMI Environmental Solutions, I
0.98+0.07
XYL
Xylem Inc.
152.95+2.45